Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03600311 · ClinicalTrials.gov registry record · NA
Resistance Exercise and Protein During Weight Loss
A NA study, sponsored by University of Nebraska Lincoln.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT03600311: Completed NA study, sponsored by University of Nebraska Lincoln.
NCT03600311 is a NA study that has completed, run by University of Nebraska Lincoln. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03600311, a NA study, has completed, sponsored by University of Nebraska Lincoln.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if post-exercise protein supplementation can rescue the anabolic response of muscle and bone to resistance exercise during caloric restriction.
Primary Outcome
Measured via ELISA
Interventions
- DIETARY_SUPPLEMENT Calcium and Vitamin D
- OTHER Caloric Restriction
- DIETARY_SUPPLEMENT Post-Exercise Protein
- OTHER Energy Balance
- DIETARY_SUPPLEMENT Post-Exercise Carbohydrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-08-31 |
| Est. Completion | 2019-05-31 |
| Phase | NA |
What the finished NCT03600311 record still lists
NCT03600311 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Calcium and Vitamin D is the first listed.
NCT03600311 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03600311 about?
NCT03600311 is a clinical study titled "Resistance Exercise and Protein During Weight Loss". The purpose of this study is to determine if post-exercise protein supplementation can rescue the anabolic response of muscle and bone to resistance exercise during caloric restriction.
What is the current status of trial NCT03600311?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2018-08-31. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT03600311?
The interventions under investigation include: Calcium and Vitamin D (DIETARY_SUPPLEMENT), Caloric Restriction (OTHER), Post-Exercise Protein (DIETARY_SUPPLEMENT), Energy Balance (OTHER), Post-Exercise Carbohydrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03600311?
This trial is sponsored by University of Nebraska Lincoln, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03600311's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI